James Coyne to PLOS One: Don’t let PACE make a mockery of data sharing

Professor James Coyne yesterday posted online his letter to PLOS One complaining about the PACE authors’ failure to provide him with data from a paper published in the journal.
Coyne’s letter was premature because he had been misinformed that he would receive a response within 20 days rather than 20 working days. However, it indicated the seriousness with which he intends to pursue the request. The response – though not necessarily the data – is due by Friday, 11 December.
The authors of the £5 million PACE trial claim it showed that cognitive behavioural therapy and graded exercise therapy have some benefits for chronic fatigue syndrome but the study’s methodology and reporting have been heavily criticized.
And, Coyne told the PLOS One, “The author group has a consistent history of refusing requests to provide their data to other investigators… Richard Horton, editor of The Lancet, has gone on record with an estimate that the investigators have spent over 750,000 pounds in fighting requests to share their data.”
However, Coyne’s request breaks new ground. Authors must agree to make study data available to others as a condition of publishing in PLOS One and Coyne explicitly invoked that agreement when making his request.
Coyne told the journal, “If the PACE investigators refuse, they will be testing the commitment of PLOS to its policies and the scientific community will be watching… In the eventuality that I do not receive their data, I believe appropriate sanctions should be available for immediate application.”
Coyne’s is the latest attempt to have PACE data independently reanalysed. It follows two petitions (here and here) – one with over 11,000 signatures – and open letters from leading scientists and twelve ME/CFS organisations making similar requests.
He recently lambasted NHS Choices’ Behind the Headlines series for publishing an uncritical repetition of the PACE authors’ much-criticised claims that null long-term follow-up data from the trial favoured their interventions. He described how the news editor of Behind the Headlines used Twitter to broadcast, “Ran story about [chronic fatigue] syndrome, tried to be balanced as possible, still reckon few death threats”, followed by “ah f*** it, they’re too lazy to actually do it”.
NHS Choices has so far declined to remove the article and has issued no apology to patients for the behaviour of its employee, who remains in his post. (NHS Choices’ complaints procedure is described here. The email address for complaints is [email protected])
Coyne recently told an audience in Edinburgh that “PACE really attracts my attention because it’s so goddamn bad. It’s bad in its conduct, it’s bad in its reporting, and it’s fascinating that it’s going unchallenged. And it’s uncritically being passed on by journalists and the media with clear harm to patients.”
He continues to use social media to bring the problems with the PACE trial to a wider scientific audience. His recent blog posts include:

  • 29 October: Uninterpretable: Fatal flaws in PACE Chronic Fatigue Syndrome follow-up study
  • 11 November: Why the scientific community needs the PACE trial data to be released
  • 17 November: Data sharing policies: Do the Dutch do it better?
  • 22 November: A “moral equivalent of war” and the PACE chronic fatigue trial
  • 29 November: No Dissing! NHS Choices Behind the Headlines needs to repair relationship with its readers
  • 2 December: What it takes for Queen Mary to declare a request for scientific data “vexatious”
  • 4 December: Update on my formal request for release of the PACE trial data

Slides from his 16 November talk in Edinburgh (YouTube video here) have been viewed by over 8,000 people. He uses Twitter extensively to comment on PACE.

Facebook
Twitter
WhatsApp
Email

2 thoughts on “James Coyne to PLOS One: Don’t let PACE make a mockery of data sharing”

  1. Would it be possible to unpack what is meant by “Authors must agree to make study data available to others as a condition of publishing in PLOS One.”
    Does this mean this mean if “others” are not given access to the data Coyne is requesting that PLOS One would be obliged to remove previous coverage of and papers by the PACE authors?
    In the event of the PACE investigators refusing Professor Coyne’s request, do we know what kind of sanctions or remedial action Professor Coyne is referring to when he states “appropriate sanctions should be available for immediate application.”

Comments are closed.

Latest News

#MEAction logo is in white in the top left corner and the words Colorado State Chapter are in white laying across an image of snow capped mountains and pine trees. There is a bottom section of the image that is a green box with the words Working-With-Governors-Office-to-Create A New Senior Policy Advisor Role-Leading to Statewide Report on Long COVID

#MEAction Colorado Works With Governor’s Office to Create A New Senior Policy Advisor Role on Long COVID and Post Viral Infection Planning–Leading to Statewide Report on Long COVID

#MEAction Colorado’s first legislative effort in Colorado began with an ME/CFS day declaration in the Colorado Legislature on February 25, 2020. Representative Alex Valdez read into the legislative record a proclamation about the presence of and deleterious effects of ME in Colorado. This effort was relatively easy to accomplish and consisted of finding a representative

Read More »
Left: Woman healthy and happy standing beside her husband. Right: Sick woman in hospital bed.

Woman with Severe ME and EDS starving to death in NHS hospital

UPDATE: We want to provide a brief update on Sami Berry’s case and what she needs help with now. The situation in hospital reached the point that Sami decided she had to self-discharge to try and stay alive. She is at home with a Percutaneous Endoscopic Jejunostomy (PEJ ) tube but she needs treatment with

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top